Synthesis 2018; 50(05): 968-983
DOI: 10.1055/s-0036-1591877
short review
© Georg Thieme Verlag Stuttgart · New York

Perspective on FTY720, an Immunosuppressant

Sivaraman Balasubramaniam*
a  High Value Chemicals Group, Reliance Industries Limited, Ghansoli, Navi Mumbai 400701, India   Email: [email protected]
,
Ganapathy Subramanian Sankaran
b  University of Massachusetts Medical School, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical school, Worcester, MA-02464, USA
,
Sneh Sanjay Badle
a  High Value Chemicals Group, Reliance Industries Limited, Ghansoli, Navi Mumbai 400701, India   Email: [email protected]
› Author Affiliations
Further Information

Publication History

Received: 05 October 2017

Accepted after revision: 23 November 2017

Publication Date:
24 January 2018 (online)


Dedicated to Professor Indrapal Singh Aidhen

Abstract

FTY720 {fingolimod hydrochloride, 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride}, a novel immunosuppressant, was discovered by chemical modification based on the structure activity relationships of ISP-I (myriocin), a metabolite of the fungus Isaria­ sinclairii. This short perspective provides insights to the various strategies available in the literature for the synthesis of FTY720 and its analogues.

1 Introduction

2 Classification of Immunosuppressive Drugs

3 The Rise of FTY720

4 Different Synthetic Strategies for FTY720

5 Analogues of FTY720

6 Binding Studies of FTY720

7 Mode of Action

8 Conclusion

 
  • References

  • 1 Parkin J. Cohen B. Lancet 2001; 2: 1777
  • 2 Wiseman AC. Clin. J. Am. Soc. Nephrol. 2016; 11: 332
  • 3 Dehlink E. Gruber S. Eiwegger T. Gruber D. Mueller T. Huber W.-D. Klepetko W. Rumpold H. Urbanek R. Szépfalusi Z. Pediatrics 2006; 118: e764
  • 4 Chandrashekara S. Indian J. Pharmacol. 2012; 44: 665
  • 5 Duncan MD. Wilkes DS. Proc. Am. Thorac. Soc. 2005; 2: 449
  • 6 Shao Y. Cheng Z. Li X. Chernaya V. Wang H. Yang X.-F. J. Clin. Hematol. Oncol. 2014; 7: 80
  • 7 Confavreux C. Vukusic S. Clin. Neurol. Neurosurg. 2004; 106: 263
  • 8 Totaro R. Passacantando A. Russo T. Parzanese I. Rascente M. Marini C. Tonietti G. Carolei A. Int. J. Immunopathol. Pharmacol. 2005; 44: 377
  • 9 Genestier L. Paillot R. Fournel S. Ferraro C. Miossec P. Revillard JP. J. Clin. Invest. 1998; 15: 322
  • 10 Luzina IG. Keegan AD. Heller NM. Rook GA. W. Shea-Donohue T. Atamas SP. J. Leukocyte Biol. 2012; 92: 1
  • 11 Fiorentino DF. Zlotnik A. Mosmann TR. Howard M. O’Garra A. J. Immunol. 1991; 147: 3815
  • 12 Canafax DM. Ascher NL. Clin. Pharm. 1983; 2: 515
  • 13 Coutinho AE. Chapman KE. Mol. Cell Endocrinol. 2011; 15: 2
  • 14 Sehgal SN. Transplant Proc. 2003; 35: 7S
  • 15 Wilde MI. Goa KL. Drugs 1996; 51: 865
  • 16 Van Assche G. Magdelaine-Beuzelin C. D’Haens G. Baert F. Noman M. Vermeire S. Ternant D. Watier H. Paintaud G. Rutgeerts P. Gastroenterol. 2008; 134: 1861
  • 17 Orlicka K. Barnes E. Culver EL. Ther. Adv. Chronic Dis. 2013; 4: 167
  • 18 Salis P. Caccamo C. Verzaro R. Gruttadauria S. Artero M. Biol.: Targets Ther. 2008; 2: 175
  • 19 Emre S. Gondolesi G. Polat K. Ben-Haim M. Artis T. Fishbein TM. Sheiner PA. Kim-Schluger L. Schwartz ME. Miller CM. Liver Transpl. 2001; 7: 220
  • 20 Fleischmann R. Stern R. Iqbal I. Expert Opin. Biol. Ther. 2004; 4: 1333
  • 21 Johnson HM. Blalock JE. Infect. Immun. 1980; 29: 301
  • 22 McHugh SM. Rifkin IR. Deighton J. Wilson AB. Lachmann PJ. Lockwood CM. Ewan PW. Clin. Exp. Immunol. 1995; 99: 160
  • 23 Yoshikawa M. Yokokawa Y. Okuno Y. Murakami N. Chem. Pharm. Bull. 1994; 42: 994
  • 24 Fujita T. Inoue K. Yamamoto S. Ikumoto T. Sasaki S. Toyama R. Chiba K. Hoshino Y. Okumoto T. J. Antibiot. 1994; 47: 208
  • 25 Fujita T. Hirose R. Yoneta M. Sasaki S. Inoue K. Kiuchi M. Hirase S. Chiba K. Sakamoto H. Arita M. J. Med. Chem. 1996; 39: 4451 ; and references cited therein
  • 26 Mandala S. Hajdu R. Bergstrom J. Quackenbush E. Xie J. Milligan J. Thornton R. Shei G.-J. Card D. Keohane C. Rosenbach M. Hale J. Lynch CL. Rupprecht K. Parsons W. Rosen H. Science (Washington, D. C.) 2002; 296: 346
  • 27 Adachi K. Chiba K. Perspect. Med. Chem. 2007; 1: 11
  • 28 Adachi K. Kohara T. Nakao N. Arita M. Chiba K. Mishina T. Sasaki S. Fujita T. Bioorg. Med. Chem. Lett. 1995; 5: 853
  • 29 Durand P. Peralba P. Sierra F. Renaut P. Synthesis 2000; 505
    • 30a Matsumoto N. Hirose R. Sasaki S. Fujita T. Chem. Pharm. Bull. 2008; 56: 595
    • 30b Maruthi RN. Venkateswara RB. Siddaiah V. Der Pharma Chem. 2017; 9: 36
    • 30c Yan N. Chen K. Bai X. Bi L. Yao L. Chem. Cent. J. 2015; 9: 1
  • 31 Seidel G. Laurich D. Fürstner A. J. Org. Chem. 2004; 69: 3950
  • 32 Kim S. Lee H. Lee M. Lee T. Synthesis 2006; 753
  • 33 Sugiyama S. Arai S. Kiriyama M. Ishii K. Chem. Pharm. Bull. 2005; 53: 100
  • 34 Balasubramaniam S. Annamalai S. Aidhen IS. Synlett 2007; 2841
  • 35 Calzavara J. McNulty J. Tetrahedron Lett. 2011; 52: 5672
  • 36 Kalita B. Barua NC. Bezbarua M. Bez G. Synlett 2001; 1411
  • 37 Lipshutz BH. Blomgren PA. Kim S.-K. Tetrahedron Lett. 1999; 40: 197
  • 38 Lu X. Bittman R. Tetrahedron Lett. 2006; 47: 825
  • 39 Mei T.-W. Luo Y. Feng X.-J. Lu W. Yang B. Tetrahedron 2013; 69: 2927
  • 40 Feng X. Mei Y. Luo Y. Lu W. Monatsh. Chem. 2012; 143: 161
  • 41 Calleja J. Pla D. Gorman TW. Domingo V. Haffemayer B. Gaunt MJ. Nat. Chem. 2015; 7: 1009
  • 42 Kiuchi M. Adachi K. Kohara T. Teshima K. Masubuchi Y. Mishina T. Fujita T. Bioorg. Med. Chem. Lett. 1998; 8: 101
  • 43 Zivkovic A. Stark H. Tetrahedron Lett. 2010; 51: 3769
    • 44a Hanessian S. Charron G. Billich A. Guerini D. Bioorg. Med. Chem. Lett. 2007; 17: 491
    • 44b Fransson R. McCracken AN. Chen B. McMonigle RJ. Edinger AL. Hanessian S. ACS Med. Chem. Lett. 2013; 4: 969
    • 44c Chen B. Roy SG. McMonigle RJ. Keebaugh A. McCracken AN. Selwan E. Fransson R. Fallegger D. Huwiler A. Kleinman MT. Edinger AL. Hanessian S. ACS Chem. Biol. 2016; 11: 409
  • 45 Lim KG. Sun C. Bittman R. Pyne NJ. Pyne S. Cell. Signalling 2011; 23: 1590
  • 46 Turgut GC. Doyduk D. Yildirir Y. Yavuz S. Akdemir A. Disli A. Şen A. Bioorg. Med. Chem. 2017; 25: 483
  • 47 Borkar SR. Bej R. Aidhen IS. ARKIVOC 2016; (ii): 148 ; http://www.arkat-usa.org/home
    • 48a Nakano T. Miyahara M. Itoh T. Kamimura A. Eur. J. Org. Chem. 2012; 2161
    • 48b Toop HD. Don AS. Morris JC. Org. Biomol. Chem. 2015; 13: 11593
    • 49a Enoru JO. Yang B. Krishnamachari S. Villanueva E. DeMaio W. Watanyar A. Chinnasamy R. Arterburn JB. Perez RG. PLOS One 2016; 11: e0162162
    • 49b Kovarik JM. Schmouder RL. Slade AJ. Ther. Drug Monit. 2004; 26: 585
    • 49c Chew WS. Wang W. Deron R. Herr DR. Pharmacol. Res. 2016; 113: 521 ; and references cites therein
  • 50 Matsumoto N. Kohno T. Uchida S. Shimizu T. Kusumoto H. Hirose R. Yanada K. Kurio W. Yamaguchi S. Watabe K. Fujita T. Bioorg. Med. Chem. 2006; 14: 4182
  • 51 Fujita T. Matsumoto N. Uchida S. Kohno T. Shimizu T. Hirose R. Yanada K. Kurio W. Watabe K. Bioorg. Med. Chem. Lett. 2000; 10: 337
  • 52 Sun C. Bittman R. J. Org. Chem. 2006; 71: 2200
  • 53 Briard E. Orain D. Beerli C. Billich A. Streiff M. Bigaud M. Auberson YP. ChemMedChem 2011; 6: 667
  • 54 Shaikh RS. Schilson SS. Wagner S. Hermann S. Keul P. Levkau B. Schäfers M. Haufe G. J. Med. Chem. 2015; 58: 3471
  • 55 Rivera J. Proia RL. Olivera A. Nat. Rev. Immunol. 2008; 8: 753
  • 56 Brinkmann V. Yonsei Med. J. 2004; 45: 991
  • 57 Habicht A. Clarkson MR. Yang J. Henderson J. Brinkmann V. Fernandes S. Jurewicz M. Yuan X. Sayegh MH. J. Immunol. 2006; 176: 36
    • 58a Chun J. Hartung H.-P. Clin. Neuropharmacol. 2010; 33: 91
    • 58b Strader CR. Pearce CJ. Oberlies NH. J. Nat. Prod. 2011; 74: 900
    • 59a Mazzola MA. Raheja R. Murugaiyan G. Rajabi H. Kumar D. Pertel T. Regev K. Griffin R. Aly L. Kivisakk P. Nejad P. Patel B. Gwanyalla N. Hei H. Glanz B. Chitnis T. Weiner HL. Gandhi RJ. Neuroinflammation 2015; 12: 245
    • 59b Brinkmann V. Billich A. Baumruker T. Heining P. Schmouder R. Francis G. Aradhye S. Burtin P. Nat. Rev. Drug Discovery 2010; 9: 883
  • 60 Leypoldt F. Münchau A. Moeller F. Bester M. Gerloff C. Heesen C. Neurology 2009; 72: 1022